Pradhan Manohar, Abeler Vera M, Danielsen Håvard E, Tropé Claes G, Risberg Björn Ake
Pathology Clinic, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway.
Mod Pathol. 2006 Sep;19(9):1227-35. doi: 10.1038/modpathol.3800641. Epub 2006 May 26.
Image cytometric DNA ploidy analysis of endometrial carcinomas was performed to determine whether ploidy status and ploidy-related parameters like DNA index, percentage of cells exceeding 5c and 9c, correlate with histologic subtype. This is a prospective study of 391 patients with stage I endometrial carcinoma which included 331 (85%) endometrioid adenocarcinoma, 22 (6%) serous adenocarcinoma, 7 (2%) clear cell adenocarcinoma, 2 (0.5%) small cell carcinoma, 1 (0.3%) undifferentiated carcinoma, and 28 (7%) unclassifiable adenocarcinoma. Twenty-five percent of endometrioid adenocarcinomas were non-diploid. In contrast, all clear cell adenocarcinomas and 21/22 (95%) of serous adenocarcinomas were non-diploid. Hyperdiploidy (25 cases) was found only in endometrioid adenocarcinomas. Mean DNA index of the stemline in serous adenocarcinoma (1.72) and clear cell adenocarcinoma (1.81) was higher than in endometrioid adenocarcinoma (1.1). The difference in ploidy-related parameters between endometrioid adenocarcinoma and serous adenocarcinoma was highly significant (P<0.001). In addition, Grade 3 endometrioid adenocarcinoma showed significant difference in all ploidy-related parameters compared with grade 1 and grade 2 tumors (P<0.001). Our results show that DNA ploidy-related parameters may be valuable in subtyping histologically difficult cases of endometrial carcinomas.
对子宫内膜癌进行图像细胞术DNA倍体分析,以确定倍体状态以及诸如DNA指数、超过5c和9c的细胞百分比等倍体相关参数是否与组织学亚型相关。这是一项对391例I期子宫内膜癌患者的前瞻性研究,其中包括331例(85%)子宫内膜样腺癌、22例(6%)浆液性腺癌、7例(2%)透明细胞腺癌、2例(0.5%)小细胞癌、1例(0.3%)未分化癌以及28例(7%)无法分类的腺癌。25%的子宫内膜样腺癌为非二倍体。相比之下,所有透明细胞腺癌以及22例中的21例(95%)浆液性腺癌均为非二倍体。超二倍体(25例)仅在子宫内膜样腺癌中发现。浆液性腺癌(1.72)和透明细胞腺癌(1.81)的干系平均DNA指数高于子宫内膜样腺癌(1.1)。子宫内膜样腺癌和浆液性腺癌之间倍体相关参数的差异具有高度显著性(P<0.001)。此外,3级子宫内膜样腺癌与1级和2级肿瘤相比,在所有倍体相关参数上均显示出显著差异(P<0.001)。我们的结果表明,DNA倍体相关参数可能有助于对组织学诊断困难的子宫内膜癌病例进行亚型分类。